cis-2-(tert-Butoxycarbonyl)-6-fluoro-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
95%
- Product Code: 87036
CAS:
1272757-81-9
Molecular Weight: | 259.27 g./mol | Molecular Formula: | C₁₂H₁₈FNO₄ |
---|---|---|---|
EC Number: | MDL Number: | MFCD20231066 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules. Its structure is particularly valuable in the development of drugs targeting neurological disorders, where the bicyclic framework and functional groups enhance binding affinity and selectivity. It is also employed in the preparation of peptidomimetics, which mimic peptides and are used to create more stable and bioavailable therapeutic agents. Additionally, its fluorine atom makes it a useful building block in the design of radiopharmaceuticals for imaging and diagnostic purposes. The tert-butoxycarbonyl (Boc) protecting group allows for controlled deprotection during synthetic processes, ensuring precision in drug development.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | £585.21 |
+
-
|
0.250 | 10-20 days | £1,135.22 |
+
-
|
cis-2-(tert-Butoxycarbonyl)-6-fluoro-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of complex organic molecules. Its structure is particularly valuable in the development of drugs targeting neurological disorders, where the bicyclic framework and functional groups enhance binding affinity and selectivity. It is also employed in the preparation of peptidomimetics, which mimic peptides and are used to create more stable and bioavailable therapeutic agents. Additionally, its fluorine atom makes it a useful building block in the design of radiopharmaceuticals for imaging and diagnostic purposes. The tert-butoxycarbonyl (Boc) protecting group allows for controlled deprotection during synthetic processes, ensuring precision in drug development.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :